Melanocortin subtype-4 receptor agonists containing a piperazine core with substituted aryl sulfonamides

The biological activity for a set of melanocortin-4 receptor (MC4R) agonists containing a piperazine core with an ortho-substituted aryl sulfonamide is described. Compounds from this set had binding and functional activities at MC4R less than 30 nM. The most selective compound in this series was >...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2005-03, Vol.15 (6), p.1623-1627
Hauptverfasser: Fotsch, Christopher, Han, Nianhe, Arasasingham, Premilla, Bo, Yunxin, Carmouche, Michelle, Chen, Ning, Davis, James, Goldberg, Martin H., Hale, Clarence, Hsieh, Feng-Yin, Kelly, Michael G., Liu, Qingyian, Norman, Mark H., Smith, Duncan M., Stec, Markian, Tamayo, Nuria, Xi, Ning, Xu, Shimin, Bannon, Anthony W., Baumgartner, James W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The biological activity for a set of melanocortin-4 receptor (MC4R) agonists containing a piperazine core with an ortho-substituted aryl sulfonamide is described. Compounds from this set had binding and functional activities at MC4R less than 30 nM. The most selective compound in this series was >25,000-fold more potent at MC4R than MC3R, and 490-fold more potent at MC4R than MC5R. This compound also reduced food intake after oral dosing at 25, 50, and 100 mg kg −1 in fasted mice. The biological activity for a set of melanocortin-4 receptor (MC4R) agonists containing a piperazine core with an ortho-substituted aryl sulfonamide is described. Compounds from this set had binding and functional activities at MC4R less than 30 nM. The most selective compound in this series was >25,000-fold more potent at MC4R than MC3R, and 490-fold more potent at MC4R than MC5R. This compound also reduced food intake after oral dosing at 25, 50, and 100 mg kg −1 in fasted mice.
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2005.01.060